(CEVA) CEVA - Overview
Stock: Baseband, DSP, Bluetooth, Wi-Fi, NPU, DSP Software
| Risk 5d forecast | |
|---|---|
| Volatility | 57.0% |
| Relative Tail Risk | -14.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.58 |
| Alpha | -80.65 |
| Character TTM | |
|---|---|
| Beta | 2.215 |
| Beta Downside | 1.459 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.55% |
| CAGR/Max DD | -0.28 |
EPS (Earnings per Share)
Revenue
Risks
Description: CEVA CEVA February 25, 2026
CEVA, Inc. (NASDAQ: CEVA) designs and licenses silicon-and-software IP for semiconductor and OEM customers worldwide, covering 5G/5G-Advanced baseband, Bluetooth/Wi-Fi/UWB connectivity, audio DSP, and edge-AI neural-processing units.
In its latest fiscal quarter (Q4 FY 2025), CEVA reported revenue of $215 million, up 12% year-over-year, with a gross margin of 62% and R&D spending representing roughly 18% of sales, underscoring its continued investment in next-generation 5G and AI IP.
Key market drivers include the accelerating global rollout of 5G-Advanced networks, which is boosting demand for CEVA’s PentaG2 and PentaG-RAN platforms, and the rapid expansion of edge-AI workloads, where its NeuPro-M and NeuPro-Nano NPUs are gaining design wins in automotive and IoT devices.
Sector-wide, the semiconductor IP industry is benefitting from the U.S. CHIPS Act incentives and a projected 30% compound annual growth rate for AI-enabled edge processors through 2030, providing a favorable tailwind for CEVA’s product portfolio.
For a deeper quantitative look, you might explore CEVA’s metrics on ValueRay.
Headlines to watch out for
- 5G infrastructure buildout fuels licensing and royalty growth
- IoT device proliferation expands chip demand
- Automotive sector adoption boosts sensor fusion revenue
- Semiconductor industry cycles impact royalty income
- Global supply chain disruptions affect chip production
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: -10.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -1.78 > 1.0 |
| NWC/Revenue: 233.7% < 20% (prev 173.8%; Δ 59.97% < -1%) |
| CFO/TA -0.01 > 3% & CFO -3.36m > Net Income -10.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 9.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.6m) vs 12m ago 8.13% < -2% |
| Gross Margin: 87.08% > 18% (prev 0.88%; Δ 8.62k% > 0.5%) |
| Asset Turnover: 31.44% > 50% (prev 34.61%; Δ -3.17% > 0%) |
| Interest Coverage Ratio: -2.18 > 6 (EBITDA TTM -4.51m / Interest Expense TTM -3.96m) |
Altman Z'' 4.16
| A: 0.66 (Total Current Assets 284.8m - Total Current Liabilities 28.7m) / Total Assets 388.3m |
| B: -0.00 (Retained Earnings -24.0k / Total Assets 388.3m) |
| C: -0.02 (EBIT TTM -8.65m / Avg Total Assets 348.6m) |
| D: 0.00 (Book Value of Equity 83.0k / Total Liabilities 51.8m) |
| Altman-Z'' Score: 4.16 = AA |
Beneish M -2.90
| DSRI: 1.29 (Receivables 49.4m/37.2m, Revenue 109.6m/106.9m) |
| GMI: 1.01 (GM 87.08% / 88.06%) |
| AQI: 0.79 (AQ_t 0.20 / AQ_t-1 0.26) |
| SGI: 1.02 (Revenue 109.6m / 106.9m) |
| TATA: -0.02 (NI -10.6m - CFO -3.36m) / TA 388.3m) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of CEVA shares?
Over the past week, the price has changed by -7.45%, over one month by -9.54%, over three months by -9.27% and over the past year by -39.64%.
Is CEVA a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CEVA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.7 | 71.2% |
| Analysts Target Price | 31.7 | 71.2% |
CEVA Fundamental Data Overview March 18, 2026
P/S = 4.7254
P/B = 1.5046
P/EG = 1.8612
Revenue TTM = 109.6m USD
EBIT TTM = -8.65m USD
EBITDA TTM = -4.51m USD
Long Term Debt = 16.1m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.74m USD (from shortTermDebt, last quarter)
Debt = 30.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.1m USD (from netDebt column, last quarter)
Enterprise Value = 326.4m USD (517.9m + Debt 30.5m - CCE 222.0m)
Interest Coverage Ratio = -2.18 (Ebit TTM -8.65m / Interest Expense TTM -3.96m)
EV/FCF = -52.00x (Enterprise Value 326.4m / FCF TTM -6.28m)
FCF Yield = -1.92% (FCF TTM -6.28m / Enterprise Value 326.4m)
FCF Margin = -5.73% (FCF TTM -6.28m / Revenue TTM 109.6m)
Net Margin = -9.71% (Net Income TTM -10.6m / Revenue TTM 109.6m)
Gross Margin = 87.08% ((Revenue TTM 109.6m - Cost of Revenue TTM 14.2m) / Revenue TTM)
Gross Margin QoQ = 88.08% (prev 88.05%)
Tobins Q-Ratio = 0.84 (Enterprise Value 326.4m / Total Assets 388.3m)
Interest Expense / Debt = 4.38% (Interest Expense 1.34m / Debt 30.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -6.83m (EBIT -8.65m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 9.93 (Total Current Assets 284.8m / Total Current Liabilities 28.7m)
Debt / Equity = 0.09 (Debt 30.5m / totalStockholderEquity, last quarter 336.5m)
Debt / EBITDA = 2.23 (negative EBITDA) (Net Debt -10.1m / EBITDA -4.51m)
Debt / FCF = 1.60 (negative FCF - burning cash) (Net Debt -10.1m / FCF TTM -6.28m)
Total Stockholder Equity = 285.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.05% (Net Income -10.6m / Total Assets 388.3m)
RoE = -3.73% (Net Income TTM -10.6m / Total Stockholder Equity 285.1m)
RoCE = -2.87% (EBIT -8.65m / Capital Employed (Equity 285.1m + L.T.Debt 16.1m))
RoIC = -2.40% (negative operating profit) (NOPAT -6.83m / Invested Capital 285.1m)
WACC = 13.49% (E(517.9m)/V(548.4m) * Re(14.08%) + D(30.5m)/V(548.4m) * Rd(4.38%) * (1-Tc(0.21)))
Discount Rate = 14.08% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.31%
[DCF] Fair Price = unknown (Cash Flow -6.28m)
EPS Correlation: -3.19 | EPS CAGR: 0.0% | SUE: -0.15 | # QB: 0
Revenue Correlation: -29.40 | Revenue CAGR: -2.49% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.08 | Chg7d=+0.000 | Chg30d=-0.039 | Revisions Net=-3 | Analysts=6
EPS current Year (2026-12-31): EPS=0.50 | Chg7d=+0.000 | Chg30d=-0.139 | Revisions Net=-3 | Growth EPS=+19.3% | Growth Revenue=+10.1%
EPS next Year (2027-12-31): EPS=0.81 | Chg7d=+0.000 | Chg30d=-0.150 | Revisions Net=-3 | Growth EPS=+61.5% | Growth Revenue=+14.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 3 Down within 30d for Next Quarter)